Cargando…
Methotrexate limits inflammation through an A20-dependent cross-tolerance mechanism
OBJECTIVES: Methotrexate (MTX) is the anchor drug for treatment of rheumatoid arthritis (RA), but the mechanism of its anti-inflammatory action is not fully understood. In RA, macrophages display a proinflammatory polarisation profile that resembles granulocyte-macrophage colony-stimulating factor (...
Autores principales: | Municio, Cristina, Dominguez-Soto, Ángeles, Fuentelsaz-Romero, Sara, Lamana, Amalia, Montes, Nuria, Cuevas, Víctor D, Campos, Raquel García, Pablos, José L, González-Álvaro, Isidoro, Puig-Kröger, Amaya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5909749/ https://www.ncbi.nlm.nih.gov/pubmed/29431121 http://dx.doi.org/10.1136/annrheumdis-2017-212537 |
Ejemplares similares
-
The Macrophage Reprogramming Ability of Antifolates Reveals Soluble CD14 as a Potential Biomarker for Methotrexate Response in Rheumatoid Arthritis
por: Fuentelsaz-Romero, Sara, et al.
Publicado: (2021) -
Histone deacetylase inhibition enhances the therapeutic effects of methotrexate on primary central nervous system lymphoma
por: Fujimoto, Kenji, et al.
Publicado: (2020) -
Methotrexate-mediated activation of an AMPK-CREB-dependent pathway: a novel mechanism for vascular protection in chronic systemic inflammation
por: Thornton, C C, et al.
Publicado: (2016) -
GSK3β Inhibition Prevents Macrophage Reprogramming by High-Dose Methotrexate
por: Ríos, Israel, et al.
Publicado: (2022) -
GM-CSF Expression and Macrophage Polarization in Joints of Undifferentiated Arthritis Patients Evolving to Rheumatoid Arthritis or Psoriatic Arthritis
por: Fuentelsaz-Romero, Sara, et al.
Publicado: (2021)